Actively Recruiting
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-04-08
224
Participants Needed
1
Research Sites
573 weeks
Total Duration
On this page
Sponsors
M
Memorial Sloan Kettering Cancer Center
Lead Sponsor
C
Center for Marital and Sexual Health of South Florida
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to test two different ways to help men with sexual rehabilitation.
CONDITIONS
Official Title
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Early stage prostate cancer (Pathologic Stage 1/2 with Gleason score /=8; or Pathologic Stage 3 with Gleason score =/< 7) as per medical record
- Radical prostatectomy performed at MSKCC or another institution as per medical record
- Surgery occurred within 9 months prior to enrollment as per medical record
- Moderate erectile function before surgery, defined by specific scores on erectile function assessments
- Starting penile injections as part of erectile rehabilitation program at MSKCC as per self-report or medical record
- Able to communicate, understand, and complete questionnaires in English as judged by consenting professional
You will not qualify if you...
- Both cavernous nerves fully resected according to surgery report or progress notes
- Currently on or has history of Androgen Deprivation Therapy (ADT)
- Any indication of Prostate-Specific Antigen (PSA) presence
- Specific injection phobia as per self-report
- Unable to provide informed consent or complete study sessions and assessments as judged by consenting professional
- Current untreated major psychiatric disorder (e.g., schizophrenia, major depression) as per self-report or medical record; eligibility reviewed by study PI prior to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
Research Team
R
Rebecca Saracino, PhD
CONTACT
K
Kelly McConnell, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here